Investigación local. Conexiones humanas. WCR Miami Lakes (786) 483-7856
Volver a buscar estudiosNCT07929441
Aún no reclutaNCT07929441Registro de ClinicalTrials.gov

Retro-SCTL Space Block vs Rhomboid Intercostal Block for Analgesia After Modified Radical Mastectomy

Breast Cancer · Modified Radical Mastectomy · Postoperative Pain

LO ESENCIAL

De qué trata este estudio

El registro no identifica actualmente este estudio como reclutando. Consulta su estado antes de planificar una evaluación.

Tipo de estudio
De intervención
Fase
No aplica
Rango de edad
18 años - 70 años
Sexo admitido
Femenino
Voluntarios sanos
No aceptados
Participantes
88 Estimado

Estos son puntos de partida, no una decisión de elegibilidad. El equipo debe revisar todos los requisitos.

Las explicaciones y la navegación están en español. Los textos proporcionados por el registro, incluidos títulos, resúmenes y criterios, se conservan en su idioma original. Puedes pedir orientación en español a WCR.

Acerca de la investigación

Modified radical mastectomy causes significant acute postoperative pain. The rhomboid intercostal block (RIB) is an established posterior chest wall block for breast surgery. The retro superior costotransverse ligament space (retro-SCTLS) block is a newer paraspinal block that may spread toward the paravertebral space, giving broader dermatomal coverage of the breast and axilla. This randomized trial will compare the two blocks in 88 adult women having elective unilateral modified radical mastectomy at Mansoura University Oncology Center. Each block uses 20 mL of 0.25% bupivacaine, given before general anesthesia under light dexmedetomidine sedation. The primary outcome is total intravenous morphine consumption in the first 24 hours after surgery. Secondary outcomes include pain scores, time to first rescue analgesia, intraoperative fentanyl use, sensory block extent, nausea and vomiting, block-related adverse events, quality of recovery (QoR-15), patient satisfaction and persistent pain at 3 months.

Leer la descripción completa

Patients will be randomized 1:1 to retro-SCTLS block at T3-T4 or RIB at T5-T6, using a computer-generated sequence with variable block sizes and sequentially numbered opaque sealed envelopes. To maintain blinding, both regions will be scanned in all patients and identical dressings applied at both sites. Sensory block (cold testing, T1-T6 and axilla) will be assessed 30 minutes after injection by a blinded assessor. General anesthesia and postoperative multimodal analgesia are standardized: paracetamol 1 g IV every 6 h and ketorolac 30 mg IV every 12 h, with rescue morphine 2 mg IV for NRS ≥ 4. The primary analysis is intention-to-treat using the Mann-Whitney U test, with the Hodges-Lehmann median difference and 95% CI. Assuming a 2 mg difference and a conservative SD of 3.1 mg (two-sided α 0.05, 80% power), 39 patients per group are required; 44 per group (88 total) will be enrolled to allow for 10% dropout.

¿Quién podría participar?

La lista siguiente contiene el texto del patrocinador. Puede incluir condiciones, tratamientos previos, resultados de pruebas y otros requisitos. Aparecer en tu búsqueda no significa que califiques.

Inclusion Criteria:

  • Female patients aged 18 to 70 years
  • American Society of Anesthesiologists (ASA) physical status I or II
  • Scheduled for elective unilateral modified radical mastectomy under general anesthesia
  • Able to provide written informed consent and to cooperate with pre-induction sedation and sensory assessment

Exclusion Criteria:

  • Known allergy to local anesthetics, dexmedetomidine, morphine, paracetamol, or non-steroidal anti-inflammatory drugs (NSAIDs)
  • Coagulopathy or any other contraindication to regional anesthesia
  • Infection at the block injection site
  • Body mass index (BMI) greater than 40 kg/m²
  • Significant cardiac, hepatic, or renal impairment (eGFR \< 60 mL/min/1.73 m²)
  • Chronic opioid use (daily opioid intake for 4 weeks or more before surgery)
  • Pre-existing chest wall neuropathy or chronic pain syndrome
  • Psychiatric or cognitive disorder preventing pain reporting or cooperation with sedation
  • Pregnancy
  • Bilateral breast surgery or immediate breast reconstruction
  • Previous ipsilateral breast or chest wall surgery (other than diagnostic biopsy)
  • Thoracic spine deformity or previous thoracic spine surgery
  • Contraindication to NSAIDs (e.g., active peptic ulcer disease)
  • Hemodynamic instability or baseline bradycardia (heart rate \< 50 bpm) precluding dexmedetomidine use
Entiende la evaluación inicial

Tratamiento, grupos y participación

El registro puede describir tratamientos y duración sin incluir un calendario completo. Pide al equipo las visitas, procedimientos, riesgos, costos y alternativas. Mantén tu atención habitual salvo que tu médico te indique un cambio.

Asignación
Asignación al azar
Enmascaramiento
Enmascaramiento triple
Retro-SCTLS block

Ultrasound-guided retro superior costotransverse ligament space block at T3-T4 with 20 mL of 0.25% bupivacaine, before induction under dexmedetomidine sedation.

Procedure: Retro Superior Costotransverse Ligament Space Block

Rhomboid intercostal block

Ultrasound-guided RIB at T5-T6 with 20 mL of 0.25% bupivacaine, before induction under dexmedetomidine sedation.

Procedure: Rhomboid Intercostal Block

Retro Superior Costotransverse Ligament Space Block PROCEDURE

Single-injection block at T3-T4 under ultrasound guidance, with 20 mL of 0.25% bupivacaine injected into the space posterior to the superior costotransverse ligament. It is performed before general anesthesia under standardized dexmedetomidine sedation (0.5 mcg/kg load, then 0.3 mcg/kg/h).

Rhomboid Intercostal Block PROCEDURE

Single-injection block at T5-T6 under ultrasound guidance, with 20 mL of 0.25% bupivacaine injected into the fascial plane between the rhomboid major and intercostal muscles, medial to the scapula. It is performed before general anesthesia under the same standardized dexmedetomidine sedation (0.5 mcg/kg load, then 0.3 mcg/kg/h).

Prepara tus preguntas

Qué evalúan los investigadores

Estas medidas indican qué se estudia. No prueban que un tratamiento funcione.

Medidas principales

Cumulative 24-hour intravenous morphine consumption

Plazo: From arrival in the post-anesthesia care unit (PACU) to 24 hours postoperatively

Total rescue IV morphine (mg) given in the first 24 hours after surgery. Rescue morphine 2 mg IV is given when NRS at rest is ≥ 4 or on patient request, repeated every 10 minutes until NRS is \< 4.

Medidas secundarias

Postoperative pain scores at rest and on movement

Plazo: 1, 2, 4, 6, 12 and 24 hours after PACU arrival

Pain intensity on the Numerical Rating Scale (0 = no pain, 10 = worst imaginable pain), at rest and during ipsilateral shoulder abduction to 90°. If abduction isn't tolerated, three deep breaths are used instead.

Time to first rescue analgesia

Plazo: From PACU arrival to the first rescue morphine dose, assessed up to 24 hours postoperatively

Time (minutes) from PACU arrival to the first rescue morphine dose. Patients who need no rescue are censored at 24 hours.

Total intraoperative fentanyl consumption

Plazo: During surgery: from induction of anesthesia to end of surgery (approximately 2-3 hours)

Total fentanyl (mcg) given during surgery, including the induction dose and rescue doses (0.5 mcg/kg). Rescue is triggered when MAP or HR rises \> 20% above the pre-incision baseline for ≥ 2 minutes.

Extent of sensory block

Plazo: 30 minutes after block injection

Number of dermatomes (T1-T6 and axilla) with reduced or absent cold sensation (ethyl chloride) on the operative side compared with the contralateral side. Block success is defined as ≥ 3 contiguous dermatomes.

Incidence of postoperative nausea and vomiting (PONV)

Plazo: Assessed at 1, 2, 4, 6, 12, and 24 hours after PACU arrival (cumulative incidence up to 24 hours)

Number of patients with any episode of nausea, retching or vomiting.

Rescue antiemetic requirement

Plazo: Assessed at 1, 2, 4, 6, 12, and 24 hours after PACU arrival (cumulative requirement up to 24 hours)

Number of patients needing rescue metoclopramide 10 mg IV.

Block performance time

Plazo: Periprocedural: during block performance, before induction of anesthesia

Time (seconds) from first placement of the ultrasound probe on the skin to needle withdrawal.

Number of needle passes

Plazo: Periprocedural: during block performance, before induction of anesthesia

Number of needle redirections needed to reach the target plane (maximum 3).

Incidence of block-related adverse events

Plazo: From block performance up to 24 hours postoperatively

Number of patients with any of the following:

hypotension (MAP \< 65 mmHg or \> 20% decrease from baseline) bradycardia (HR \< 50 bpm) vascular puncture, hematoma or puncture-site infection pneumothorax (confirmed by lung ultrasound or chest X-ray) contralateral sensory block suggesting epidural spread local anesthetic systemic toxicity

Sedation score

Plazo: 1, 2, 4, 6, 12 and 24 hours after PACU arrival

Ramsay Sedation Scale (1 = anxious/agitated to 6 = no response).

Quality of recovery (QoR-15)

Plazo: Baseline (preoperatively, on the day of surgery) and 24 hours postoperatively

Quality of Recovery-15 questionnaire score (range 0-150; higher scores mean better recovery).

Patient satisfaction with postoperative analgesia

Plazo: 24 hours postoperatively

5-point Likert scale (1 = very dissatisfied, 5 = very satisfied).

Persistent postsurgical pain

Plazo: 3 months postoperatively

Incidence of pain at or near the surgical site present on ≥ 4 of the 7 days before assessment, by structured telephone interview. Intensity is rated on the NRS (0-10), and neuropathic features are screened with the DN4 interview questionnaire (DN4i, score 0-7; ≥ 3 suggests neuropathic pain).

El registro no indica resultados publicados.

Revisa las tablas completas y sus limitaciones en el registro oficial.

Abrir resultados oficiales ↗

Centros de investigación (1)

El estado general puede diferir del estado de un centro. Confirma la disponibilidad antes de trasladarte.

1 centros

Oncology Center Mansoura University (OCMU)Al Mansurah, Dakahlia Governorate, EgyptEstado desconocido
Mohamed Ahmed Tolba, MDCONTACTm_atolba1234@mans.edu.eg+966 50 743 9018
Dina Abdellatif Elebedy, MDCONTACTdinaelebedy@mans.edu.eg+201008019744
Mohamed Ahmed Tolba, MDPRINCIPAL_INVESTIGATOR
Dina Abdellatif Elebedy, MDSUB_INVESTIGATOR
Ver ubicación en el mapa ↗

Equipo y fechas

Patrocinador principal
Mansoura University
Inicio del estudio
7 nov 2026 Estimado
Finalización primaria
20 abr 2027 Estimado
Finalización del estudio
30 abr 2027 Estimado
Primera publicación
10 nov 2026 Real
Última actualización
10 nov 2026 Real

Contactos oficiales del estudio

Mohamed Ahmed Tolba, MDCONTACTm_atolba1234@mans.edu.eg+966 50 743 9018
Dina Abdellatif Elebedy, MDCONTACTdinaelebedy@mans.edu.eg+201008019744
Título oficial del estudio

Ultrasound-Guided Retro Superior Costotransverse Ligament Space Block Versus Rhomboid Intercostal Block for Postoperative Analgesia After Modified Radical Mastectomy: A Randomized, Blinded Superiority Trial

EL PRÓXIMO PASO, CON APOYO HUMANO

Consulta a Wellness Clinical Research

Tu mensaje va a WCR, incluso si otra organización realiza este estudio. WCR puede orientarte, pero podría no realizar este estudio, tener acceso a su equipo ni poder inscribirte.

No incluyas expedientes médicos, diagnósticos, medicamentos, números de seguro ni otros datos sensibles. Este formulario es para preguntas generales, no para atención urgente.

Enviar una pregunta no te inscribe en un estudio.

Fuente: API v2 de ClinicalTrials.gov. Patrocinadores e investigadores envían la información. La NLM no aprueba la seguridad ni la ciencia de todos los estudios registrados. Aviso del registro.

Consultado: 12 nov 2026 · Última actualización del registro: 10 nov 2026